This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
An Australian biotechnology company is building what could be the first AI-driven hospital in Vietnam. WHAT IT'S ABOUT The MedArmor AI Hospital will pursue a preventive healthcare model, emphasising early disease detection and timely interventions. It will be underpinned by AI and virtual care technologies.
By Aparajita Lath In January, the Federal Trade Commission (FTC) released a new draft rule that would categorically ban non-compete clauses — contractual terms between an employer and an employee that prevent subsequent employment at a competing firm — across the country.
What You Should Know: Range Biotechnologies (Range Bio) announced $5.2M Thus, developing more effective ways to diagnose, treat, and prevent diseases such as cardiovascular disease, cancer, COPD, MS, and more. Proteomics, the study of proteins in the body, has the potential to improve human health in several ways.
What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D.,
These solutions, provided to pharmaceutical companies, government labs, and researchers, are designed to accelerate the study and prevention of diseases in the fields of obesity, diabetes, cancer, and regenerative medicines. Trivia Frazier, Ph.D., Co-Founder, President, & CEO of Obatala Sciences, Inc.
It provides tailored legal and regulatory support to patients, researchers, businesses, and incubators, driving progress in healthcare and biotechnology. Another main study in this key area involves the study of biotechnologies and so-called biosolutions. We recently published a study for the European Commission on these issues.
What You Should Know: – clock.bio , a healthspan biotechnology company based at the Milner Therapeutics Institute in Cambridge, has secured $5.3M A Vision for Increased Healthspan clock.bio’s mission is to increase human healthspan by developing treatments that prevent and treat age-related diseases.
Many of these household products actually include flame retardants, chemicals added to materials to prevent or reduce the spread of fire. Her research interests include genetics, environmental health sciences, novel biotechnologies, and the FDA regulatory process. At HLS, Jessica is co-president of the Harvard Health Law Society.
Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. will help LHN members bring innovative cancer prevention testing to the communities they serve. A Comprehensive Multiomics Platform for the Early Detection of Cancer. Trial participation?will
IBM and Google) to biotechnology (e.g., Second, even if a license isn’t granted, Moderna’s public promise justified reliance by others, and Moderna is thus prevented from retracting that promise under the doctrine of “promissory estoppel.” Tesla and Toyota) to software (e.g, According to the U.S. Why Should We Care?
As is often the case in today’s healthcare environment, advanced technologies powered by artificial intelligence (AI) and machine learning (ML) are emerging as a potential solution, helping to both prevent falls and accelerate recovery when falls lead to injury – particularly when they can be used in the comfort of the patient’s home.
In recent decades, advancements in biotechnology have made it possible to develop synthetic nuclei. The binding of an antibody to its antigen initiates a detailed immune response aimed at a particular pathogen and helps prevent infection. This binding helps eliminate the pathogens without harming the body’s cells.
Since biotechnology inventions can be covered by several patents, each of which may not be easy to identify through public searches, the decision to publish a consolidated list of patents is a move in the right direction. In their initial August 2022 complaint , Moderna alleged that three of its mRNA patents were infringed by Pfizer/BioNTech.
Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease.
Sonia Fischer, Customer Integrations Manager, IQVIA In the age of biotechnology , biosample collection has become an essential part of medical research. The extra effort may require a greater initial investment, but it could potentially prevent the need to recruit additional patients.
Conventional negligence theory suggests that since it is likely a lab leak will happen, and reasonably foreseeable that microorganisms will escape (perhaps one engineered to infect humans), reasonable preventive measures are indicated. So, what could those be? Other countries have not been as diligent. appeared first on Bill of Health.
These five students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from Harvard Law School. At the law school, Adithi is interested in examining how emerging biotechnologies in regenerative medicine intersect with patient privacy and other ownership rights.
Dr. Devenot is also an affiliated researcher with Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Neşe Devenot, PhD is a Senior Lecturer in the University Writing Program at the Johns Hopkins University.
With advancements in genomics, biotechnology, and robotics, the potential to revolutionize medicine is enormous. Whether in healthcare or entertainment, technology continues to redefine how we interact with services and each other. These advancements are paving the way for a more efficient, effective, and personalized healthcare system.
She previously served as a Research Fellow in Medicine, Artificial Intelligence, and Law at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School for the Project on Precision Medicine, Artificial Intelligence, and the Law ( PMAIL ). This first installment of responses looks at data privacy concerns.
Panelists discussed these topics during a recent webinar hosted by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. The unwillingness to follow the science combined with a cultural commitment to punishment has really prevented us from making smart choices.” First, BJ Casey , Christina L.
The Principles affirm States’ obligations to cooperate towards measures that prepare for, prevent and respond to public health emergencies. She concludes that “strong, well-coordinated and resilient public health care services play a vital role in preventing and responding to public health crises.” Ahmed et al.
Biovac will become the first African producer of IPV, directly contributing to the continent’s goal of producing 60% of its vaccines locally by 2040, as envisioned by the Africa Centers for Disease Control and Prevention. Sanofi’s Legacy of Polio Eradication Sanofi boasts a long-standing commitment to polio eradication.
In the context of an organization like Gather Well—namely, a recent extension of a lineage that has failed to prevent, and even enabled, harm—bioethicists taking on ethics consultancies face complex challenges. Neşe Devenot, PhD is a Senior Lecturer in the University Writing Program at the Johns Hopkins University.
Recalling the increasing recurrence of public health emergencies over the past century and contemplating the possibility of the continued proliferation of emergencies, the Principles clarify human rights law obligations and standards applicable in prevention of, preparation for, response to, and recovery from, such emergencies.
A global public good refers to something that everyone can access (“nonexcludable”) and whose use by one does not prevent use by others (“nonrivalrous”). This prevents competitors from entering the market, as they would have to replicate costly clinical trials from scratch. What does that mean? Towards A Global Public Goods Approach.
In the area of testing and disease tracking, the Africa CDC has partnered with Illumina, Oxford Nanopore, the Bill and Melinda Gates Foundation, the US Centers for Disease Control and Prevention, and Microsoft on a $100 million African Pathogen Genomics Initiative to boost disease tracking and emergency response capacity in Africa.
This could prevent patients from accessing treatments that improve on or offer different benefits from existing therapies, even when the new drug and existing drug are completely unrelated. Startups adds the concern that biotechnology startups need genus protection to attract early-stage funding and acquisitions. The Alliance of U.S.
To navigate the myriad interests and stakes involved in creating federal psychedelic policy, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School convened a virtual panel discussion with three leading psychedelic policy advocates. By James R. A full video of the event is available below.
The innovation-security tradeoff is a familiar trope in biotechnology, but the main character of the direct-to-consumer tissue-based service story is less so. The FTC can also make rules to help prevent data breaches before they occur, and is in fact moving towards formal rulemaking in consumer privacy. Turning to the FTC?
How should scientists, policy makers, and governments balance efforts to address the current pandemic with initiatives to prevent the next one? These global surveillance systems are only possible with sustained research funding for viral prevention. By Matthew Bauer. We have seen this play out before during the 2003 SARS crisis.
Nectin) a biotechnology company developing novel targeted immunotherapies to address resistance to approved immune-oncology treatments, announced it has extended its Series A financing to over $25 million. What You Should Know: – Nectin Therapeutics Ltd.,
The legal and institutional regime aimed at preventing and controlling the spread of infectious diseases, grounded on the International Health Regulations (IHR) was heavily criticized. This could facilitate preparedness, preventive action, and dedication of resources, which could avert an escalation of the situation.”.
These ligaments ensure that your knee moves in a controlled manner, preventing unwanted wobbling or instability. 3 These include the Medial and Lateral Collateral Ligaments (MCL and LCL) on the sides of your knee to prevent it from moving too much side-to-side. References National Center for Biotechnology Information.
Innoforce and Hibiscus BioVentures forms a strategic partnership to leverage their combined resources to advance new Advanced Therapy Medicinal Products (ATMPs) and biologic which will accelerate Hibiscus BioTechnology Studio Companies’ product pipeline. Komodo Health & Fight CRC Use Real-World Data to Identify Top Providers.
The goal of such a legal instrument is to enhance the world’s capacity to predict, prevent, detect, assess, and respond to future disease outbreaks. To make sure that COVID-19 is the last pandemic of its kind, the international community is considering the creation of a new pandemic treaty.
At the research and development (R&D) stage, government funders can bind producers to equity goals through targeted contractual provisions, as we explain in a recently-published Nature Biotechnology article. We summarize our proposals in the following sections. Pandemic Technology and the Contract Landscape.
First, provided that HHGE is safe and effective, an overwhelming majority of participants supported allowing the use of HHGE not only to prevent genetic health conditions, but also to attain immunity against TB and HIV/AIDS. The results of these deliberations are summarized briefly below.
Nevertheless, a multilateral recognition of the need to ensure the sharing of pandemic health technologies and the IP associated with it could prevent a situation in which the inequitable access to lifesaving technologies is a serious impediment to addressing pandemics.
Many are choosing to defer necessary medical care including preventative screenings. Prior to founding MDsave, Paul served as Chief Operating Officer for Diagnostix Network Alliance, a healthcare biotechnology sales organization that achieved over $25 million in annual sales in year one. What is also likely to suffer this year?
What was once a disease that could go very wrong has become something which is not only preventable but also treatable. If we could widely distribute a highly effective pill that actually treats COVID, that would also be as much of a game changer as the vaccine itself. This is, in my view, a long-term solution to COVID.
This should prevent unfair dismissal as well as any other form of discrimination within the workplace, although this protection only applies from when the pregnancy begins , so until any uterus transplant recipient becomes pregnant, they are not covered by this legislation.
Many of these developments are predicated on data and AI algorithms to prevent, diagnose, treat, and monitor sources of epidemic diseases, such as the ongoing pandemic and other pathogenic outbreaks.
Doses assigned to this category would be allocated to the countries or regions with the highest public health need during the relevant public health crisis — e.g., those where the burden of a given vaccine-preventable disease is the highest. Operative criteria of “burden” and related considerations (e.g., the infection rate?
We organize all of the trending information in your field so you don't have to. Join 19,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content